Discover how safely we lead our customers through early stage product development research and fully customized in-vivo and in-vitro studies. View more
See how we monitor and support the planning and set-up of studies at an early stage. View more
Experience how we always strive for the best solution, generating tailor-made products and services in drug research and testing. View more
Find out, why we consider ourselves as our clients extended arm in drug development, fast, efficient and interdisciplinary. View more
Discover our turnkey preclinical package solutions being entirely customized to customer needs. View more
Feel the dedication and passion for our customers.
Discover how our advisory team stands at their side on the way to future success. View more
Explore our culture of direct communication in which scientist talk with scientists, from the first contact until the final document. View more
We’re happy to attend the Bio-Europe Spring in Vienna! Visit us at the Bavarian International Pavillion (booth 28) and discuss your needs…
View more
We’re happy to attend the annual meeting of Society of Toxicology in Baltimore! Visit us at booth 2009 and discuss…
View more
The Aurigon Group proudly presents its renewed LinkedIn profile. Aurigon GmbH and ATRC Aurigon Ltd. has separate, but similar profiles…
View more
The Aurigon Group proudly announce a new paper co-authored by our colleague, Tamas Kitka in his previous position. The article,…
View more
The European Medicines Agency has recently published a wonderful and comprehensive booklet entitled “From laboratory to patient: the journey of…
View more
Source: Nature. By: Nobuyuki Tanaka, Shigeaki Kanatani [...] Peter Uhlén. Intratumoral heterogeneity is a critical factor when diagnosing and treating patients with…
View more